These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7350231)

  • 1. H-2 linked genetic control of priming for secondary cytotoxic responses to autologous cells modified with low concentrations of trinitrobenzene sulfonate.
    Polisson RP; Fujiwara H; Shearer GM
    J Immunol; 1980 Jan; 124(1):349-54. PubMed ID: 7350231
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on in vivo priming to TNP-reactive cytotoxic effector cell system. II. Augmented secondary cytotoxic response by radioresistant T cells and demonstration of differential helper activity as a function of the stimulating dose of TNP-self.
    Fujiwara H; Shearer GM
    J Immunol; 1980 Mar; 124(3):1271-6. PubMed ID: 6965689
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-H-2-linked genetic control of murine cell-mediated lympholysis to autologous cells modified with fluorescein isothiocyanate (FTC-self).
    Arora PK; Shearer GM
    J Immunol; 1982 Sep; 129(3):1200-3. PubMed ID: 6809814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic control of cell-mediated lympholysis to trinitrophenyl (TNP)-modified murine syngeneic cells. I. Expression of Ir gene function at the Cytotoxic precursor and helper cell levels in the response to TNP-H-2 b self.
    Fujiwara H; Shearer GM
    J Immunol; 1981 Mar; 126(3):1047-51. PubMed ID: 6780621
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective expansion of H-2 restricted cytotoxic T lymphocytes to TNP-self by injection of trinitrobenzene sulfonate.
    Shearer GM; Levy RB
    Ann N Y Acad Sci; 1982; 392():137-43. PubMed ID: 6814322
    [No Abstract]   [Full Text] [Related]  

  • 6. Cells treated with trinitrobenzene sulfonic acid express an antigenic determinant recognized by cytotoxic effector cells that is not detected on cells coated with trinitrophenylated proteins.
    Ciavarra R; Forman J
    J Immunol; 1980 Feb; 124(2):713-8. PubMed ID: 6153204
    [No Abstract]   [Full Text] [Related]  

  • 7. Specificity of cytotoxic effector cells directed against trinitrobenzene sulfonate-modified syngeneic cells. Failure to recognize cell surface-bound trinitrophenyl dextran.
    Henkart PA; Schmitt-Verhulst M; Shearer GM
    J Exp Med; 1977 Oct; 146(4):1068-78. PubMed ID: 70501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of H-2-linked genetic control of immune responsiveness to TNP-MSA.
    Urba WJ; Hildemann WH
    J Immunol; 1979 Jul; 123(1):209-15. PubMed ID: 448148
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell-surface antigenic modifications with trinitrophenyl sulfonate versus trifluoromethyl-dinitrophenyl sulfonate.
    Bischoff P; Maugras M; Llorens MC; Oth D
    Immunobiology; 1983 Feb; 164(1):1-12. PubMed ID: 6189780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated lympholysis responses against autologous cells modified with haptenic sulfhydryl reagents. II. Analysis of the genetic control and H-2-restricted pattern of cytotoxic responses to sulfhydryl and amino reactive reagents.
    Levy RB; Henkart PA; Shearer GM
    J Immunol; 1981 Aug; 127(2):529-34. PubMed ID: 6972968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic control of antibody responses to TNP-nuclease in vitro.
    Nadler PI; Miller GP; Sachs DH; Hodes RJ
    J Immunol; 1981 May; 126(5):1706-12. PubMed ID: 6783697
    [No Abstract]   [Full Text] [Related]  

  • 12. Naturally occurring antibodies directed to TNBS-modified cell surface but not the trinitrophenyl moiety.
    Ballas ZK; Kuppers RC
    J Immunol; 1980 Oct; 125(4):1644-9. PubMed ID: 7410849
    [No Abstract]   [Full Text] [Related]  

  • 13. H-2-linked genetic control of murine cell-mediated lympholysis to autologous cells modified with high and low concentrations of fluorescein isothiocyanate.
    Gilheany P; Arora PK; Levy RB; Shearer GM
    Cell Immunol; 1981 Mar; 59(1):97-105. PubMed ID: 7214547
    [No Abstract]   [Full Text] [Related]  

  • 14. Peptide from one of the alpha helical regions of H-2Kb can manipulate responses to the H-2Kb alloantigen in vitro and in vivo.
    Wood K; Bell Y; Morris P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):481-2. PubMed ID: 8438387
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.
    Schirmbeck R; Melber K; Kuhröber A; Janowicz ZA; Reimann J
    J Immunol; 1994 Feb; 152(3):1110-9. PubMed ID: 8301120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F1 hybrid resistance to murine plasmacytoma MOPC-70A: hybrid resistance to MOPC-70A controlled by a locus linked to H-2.
    Kaneko Y; Natsuume-Sakai S; Moriwaki K; Migita S
    J Immunol; 1980 Nov; 125(5):2031-8. PubMed ID: 7430619
    [No Abstract]   [Full Text] [Related]  

  • 17. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1+ phenotype.
    Sabapathy TK; Cheng Q; Hui KM
    Cell Immunol; 1995 Nov; 166(1):141-53. PubMed ID: 7585974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hapten-specific unresponsiveness in mice. II. Fate and distribution of 14C-TNBSA injected at tolerogenic doses.
    Huchet R; Olsson L; Grandjon D; Davies AJ
    Immunology; 1980 Feb; 39(2):275-9. PubMed ID: 7380471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.